Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical study on the immunogenicity of different rapid tick-borne encephalitis (TBE) immunization schedules with inactivated TBE vaccine
2006-006955-10Phase 2Terminated
- Sponsor
- Univ.-Prof. Dr. Helmut Mittermayer
- Start
- Jan 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of tick-borne encephalitis vaccine, inactivated in tick-borne encephalitis (TBE) (3 arms), sponsored by Univ.-Prof. Dr. Helmut Mittermayer. Primary endpoints: Primary immunogenicity (seroconversion rates) and Comparative immunogenicity between schedules. Started Jan 2007; status: terminated.
02
Drugs
tick-borne encephalitis vaccine, inactivated
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on 2006-006955-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006955-10.